Last week at the 23andMe headquarters, over 100 researchers gathered together for the company’s annual Genome Research Day.
Disruptive science can have a significant impact outside of our own domains of research and into our personal lives. Keeping abreast of these developments can help prepare and inspire.
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, and that the disease might be preventable.
Lurking quietly in the deep dark jungles of New Guinea are a group of lizards who share a rather striking feature: green blood. It’s a rare trait for vertebrates to have, but new insights into this strange blood could lead to innovative medical treatments.
The U.K. Prime Minister, Theresa May has made her first appearance in a series on industrial strategy, whereby she has pledged millions of pounds of government funding to develop artificial intelligence to transform outcomes through early diagnosis of cancer and chronic disease.
A new way to simplify complex biomolecular data about tumours could in principle make it easier to prescribe the appropriate treatment for a specific patient.
Results of an international collaboration report a new association between the PM20D1 gene and Alzheimer’s disease (AD).
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer’s disease in mice.
Researchers have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease. This is the first time researchers have successfully applied CRISPR technology to a type of inherited disease known as a dominant disorder.
Participants covering all aspects of science met at this year’s Genome-Project-write, to discuss how they were going to construct an entire genome from scratch.